Cite
HARVARD Citation
Higgs, B. et al. (n.d.). 15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients. European journal of cancer. pp. S717-. [Online].